Search Results - "Nesma Mounir"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Effect of Low-Dose Naltrexone on Egyptian Children with Intractable Epilepsy: A Case Series Study by Abokrysha, Noha, Kishk, Nirmeen, Nawito, Amani, Mounir, Nesma

    Published in Neurology India (01-11-2021)
    “…Epilepsy is a chronic neurological disorder affecting 50 million patients worldwide, in need of continuous treatment, while 30% of them are refractory to…”
    Get full text
    Journal Article
  2. 2

    The diagnostic yield of a 2-h versus a 30-min electroencephalogram for patients with altered mental status in neurological intensive care unit by Mounir, Nesma, Belal, Ehab Shaker, Abozeina, Mahmoud Fathi, Tawfeek, Aliaa Ali

    “…BackgroundThe continuous electroencephalogram (cEEG) monitoring is recommended for critical ill patients with altered mental status, The cEEG detects seizure…”
    Get full text
    Journal Article
  3. 3

    Transcranial ultrasonography as a predictor of disease progression in multiple sclerosis by Fahmy, Ebtesam, Helmy, Hanan, Merghany, Nahla Aly, Ismail, Rania Shehata, Mounir, Nesma

    “…BackgroundDevelopment of novel biomarkers for multiple sclerosis (MS) is of utmost importance to improve the capability to predict disease progression and…”
    Get full text
    Journal Article
  4. 4

    Role of circulating miR 194-5p, miR 106b, and miR 146a as potential biomarkers for epilepsy: a case-control study by Mervat Moustafa, Noha T. Abokrysha, Nermeen A. Eldesoukey, Dalia Gamil Amin, Nesma Mounir, Dalia M. Labib

    “…Abstract Background Epilepsy is a chronic neurological disease. A suitable biomarker for epilepsy diagnosis remains lacking. MicroRNAs (miRNAs) were pronounced…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Clinical Predictors of Transation to Secondary Progressive Multiple Sclerosis by Shalaby, Nevin M, Rushdi, Rufaida, Soliman, Nourhan M., Abdelbaky, Hadeel Ahmed, Elmerghany, Nahla, Mounir, Nesma, Hassan, Amr, Fahmi, Rasha M., Elsaid, Ahmed F., Mekkawy, Doaa

    Published in Multiple sclerosis and related disorders (01-03-2023)
    “…The demarcation of transition of multiple sclerosis (MS) from the relapsing remitting (RR) to the secondary progressive (SP) phase is still illusive with no…”
    Get full text
    Journal Article